Structural and Functional Differences Between Glycosylated and Non-glycosylated Forms of Human Interferon-β (IFN-β)
Laura Runkel, Werner Meier, R. Blake Pepinsky et al. · Pharmaceutical Research · 1998
Cited by 303 works. doi:10.1023/a:1011974512425
Authors
- Laura Runkel
- Werner Meier
- R. Blake Pepinsky
- Michael Karpusas
- Adrian Whitty
- Kathleen Kimball
- Margot Brickelmaier
- Celine Muldowney
- Wendy E. Jones
- Susan E. Goelz
References
- Intramuscular interferon beta‐1a for disease progression in relapsing multiple sclerosis
- The Interferon System
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
- Interferon beta‐1b is effective in relapsing‐remitting multiple sclerosis
- Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group.
- GLYCOBIOLOGY
- The interferon system. A bird's eye view of its biochemistry.
- The nonglycosylated glycoprotein of vesicular stomatitis virus is temperature-sensitive and undergoes intracellular aggregation at elevated temperatures.
- Expression of human fibroblast interferon gene in Escherichia coli
- Glycoproteins: what are the sugar chains for?